EVOK logo

Evoke Pharma (EVOK) Working Capital

Annual Working Capital

-$2.82 M
-$12.89 M-128.02%

31 December 2023

EVOK Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$4.27 M
+$1.61 M+60.29%

30 September 2024

EVOK Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EVOK Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-128.0%-23.7%
3 y3 years-261.7%-58.2%
5 y5 years-170.3%-16.9%

EVOK Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-128.0%at low-67.3%+251.4%
5 y5 years-128.0%at low-67.3%+251.4%
alltimeall time-112.7%at low-80.7%+251.4%

Evoke Pharma Working Capital History

DateAnnualQuarterly
Sept 2024
-
$4.27 M(+60.3%)
June 2024
-
$2.67 M(-23.8%)
Mar 2024
-
$3.50 M(-224.0%)
Dec 2023
-$2.82 M(-128.0%)
-$2.82 M(-150.4%)
Sept 2023
-
$5.60 M(-18.2%)
June 2023
-
$6.85 M(-17.2%)
Mar 2023
-
$8.27 M(-17.9%)
Dec 2022
$10.07 M(+10.0%)
$10.07 M(-11.5%)
Sept 2022
-
$11.38 M(-12.8%)
June 2022
-
$13.05 M(+70.2%)
Mar 2022
-
$7.67 M(-16.2%)
Dec 2021
$9.15 M(+424.6%)
$9.15 M(-10.3%)
Sept 2021
-
$10.21 M(-9.2%)
June 2021
-
$11.24 M(-13.0%)
Mar 2021
-
$12.93 M(+640.8%)
Dec 2020
$1.75 M(-58.7%)
$1.75 M(+1766.4%)
Sept 2020
-
$93.50 K(-94.0%)
June 2020
-
$1.56 M(-44.8%)
Mar 2020
-
$2.82 M(-33.4%)
Dec 2019
$4.23 M(+5.4%)
$4.23 M(-17.7%)
Sept 2019
-
$5.14 M(-18.1%)
June 2019
-
$6.28 M(+111.2%)
Mar 2019
-
$2.97 M(-25.9%)
Dec 2018
$4.01 M
$4.01 M(-25.6%)
DateAnnualQuarterly
Sept 2018
-
$5.40 M(+0.7%)
June 2018
-
$5.36 M(+22.1%)
Mar 2018
-
$4.39 M(-25.0%)
Dec 2017
$5.86 M(-25.6%)
$5.86 M(-27.7%)
Sept 2017
-
$8.10 M(-28.1%)
June 2017
-
$11.27 M(-17.7%)
Mar 2017
-
$13.69 M(+73.9%)
Dec 2016
$7.87 M(+2.4%)
$7.87 M(-19.7%)
Sept 2016
-
$9.80 M(-741.9%)
June 2016
-
-$1.53 M(-134.4%)
Mar 2016
-
$4.44 M(-42.3%)
Dec 2015
$7.69 M(-42.5%)
$7.69 M(-20.5%)
Sept 2015
-
$9.67 M(+30.4%)
June 2015
-
$7.41 M(-26.4%)
Mar 2015
-
$10.07 M(-24.7%)
Dec 2014
$13.38 M(-39.6%)
$13.38 M(+15.1%)
Sept 2014
-
$11.62 M(-23.0%)
June 2014
-
$15.10 M(-20.8%)
Mar 2014
-
$19.07 M(-13.9%)
Dec 2013
$22.15 M(-4973.7%)
$22.15 M(+5.0%)
Sept 2013
-
$21.10 M(>+9900.0%)
Mar 2013
-
$0.00(-100.0%)
Dec 2012
-$454.40 K(-179.6%)
-$454.40 K
Dec 2011
$570.80 K
-

FAQ

  • What is Evoke Pharma annual working capital?
  • What is the all time high annual working capital for Evoke Pharma?
  • What is Evoke Pharma annual working capital year-on-year change?
  • What is Evoke Pharma quarterly working capital?
  • What is the all time high quarterly working capital for Evoke Pharma?
  • What is Evoke Pharma quarterly working capital year-on-year change?

What is Evoke Pharma annual working capital?

The current annual working capital of EVOK is -$2.82 M

What is the all time high annual working capital for Evoke Pharma?

Evoke Pharma all-time high annual working capital is $22.15 M

What is Evoke Pharma annual working capital year-on-year change?

Over the past year, EVOK annual working capital has changed by -$12.89 M (-128.02%)

What is Evoke Pharma quarterly working capital?

The current quarterly working capital of EVOK is $4.27 M

What is the all time high quarterly working capital for Evoke Pharma?

Evoke Pharma all-time high quarterly working capital is $22.15 M

What is Evoke Pharma quarterly working capital year-on-year change?

Over the past year, EVOK quarterly working capital has changed by -$1.33 M (-23.71%)